Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01424358
Other study ID # 11-16008
Secondary ID 7K23DE016890-07
Status Completed
Phase N/A
First received August 22, 2011
Last updated March 23, 2015
Start date July 2011
Est. completion date September 2013

Study information

Verified date December 2012
Source Creighton University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Objective:

The experimental design is a one-site, randomized experimental web-based educational feasibility intervention trial, with approximately 50% primary care physicians (PCPs) in the intervention group and approximately 50% PCPs on the control group, giving a total of 159 participants. All 159 participants have willingly provided their e-mail addresses, as part of a survey they previously completed entitled, "Survey of Health Professionals on Oral Cancer in Ohio- Intervention to Prevent Delayed Diagnosis of Oral Cancer."


Description:

The main specific aim is to determine the short-term effectiveness of a web-based educational intervention for primary care physicians (PCPs) in Ohio to improve the following:Index of knowledge of risk factors for oral cancer, and Index of knowledge of diagnostic procedures for oral cancer

The following hypothesis will be explored: The use of a web-based educational module for PCPs in Ohio regarding oral cancer will increase the proportion of the PCPs in the high score category for the following indices: Index of knowledge of risk factors of oral cancer, and Index of knowledge of diagnostic procedures for oral cancer


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date September 2013
Est. primary completion date September 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- The PCP's who participated in Specific Aim #2 (Survey of Healthcare Professionals on Oral Cancer in Ohio ) of the NIH K23 grant proposal, "Intervention to Prevent Delayed Diagnosis of Oral Cancer", will be eligible to participate in this Web-Based Education on Oral Cancer.

- Possessing the ability to give voluntary consent to participate. Participating in the web-based educational intervention is am implication of consent.

- All participants are expected to be relatively healthy.

Exclusion Criteria:

• Unable to have access to the internet to be able to participate in the web-based education.

Study Design

Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)


Related Conditions & MeSH terms


Intervention

Other:
Web-based Educational Intervention
The intervention group will be invited to participate in the web-based educational program. PCPs in the intervention group will be asked to view the educational module which will be followed by an assessment. This group will be tested on the following knowledge outcomes: Index of knowledge of risk factor for oral cancer and Index of knowledge of diagnostic procedures for oral cancer.

Locations

Country Name City State
United States Creighton University School of Dentistry Omaha Nebraska

Sponsors (2)

Lead Sponsor Collaborator
Creighton University National Institute of Dental and Craniofacial Research (NIDCR)

Country where clinical trial is conducted

United States, 

References & Publications (8)

Canto MT, Devesa SS. Oral cavity and pharynx cancer incidence rates in the United States, 1975-1998. Oral Oncol. 2002 Sep;38(6):610-7. — View Citation

Canto MT, Drury TF, Horowitz AM. Use of skin and oral cancer examinations in the United States, 1998. Prev Med. 2003 Sep;37(3):278-82. — View Citation

Goodman HS, Yellowitz JA, Horowitz AM. Oral cancer prevention. The role of family practitioners. Arch Fam Med. 1995 Jul;4(7):628-36. Review. — View Citation

Horowitz AM, Moon HS, Goodman HS, Yellowitz JA. Maryland adults' knowledge of oral cancer and having oral cancer examinations. J Public Health Dent. 1998 Fall;58(4):281-7. — View Citation

Horowitz AM, Nourjah PA. Factors associated with having oral cancer examinations among US adults 40 years of age or older. J Public Health Dent. 1996 Fall;56(6):331-5. — View Citation

Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002 Jan-Feb;52(1):23-47. Erratum in: CA Cancer J Clin 2002 Mar-Apr;52(2):119. CA Cancer J Clin 2002 May-Jun;52(3):181-2. — View Citation

Mashberg A, Garfinkel L. Early diagnosis of oral cancer: the erythroplastic lesion in high risk sites. CA Cancer J Clin. 1978 Sep-Oct;28(5):297-303. — View Citation

Silverman S Jr. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc. 2001 Nov;132 Suppl:7S-11S. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Index of knowledge of diagnostic procedure for oral cancer The list of participants will be sent an initial email inviting them to view the module and complete a pre test (control group) or a post test (intervention group). Reminder emails will be sent every 2 months for up to 6 months following the initial email. It is expected that at least a 15% higher proportion of Intervention group PCPs will attain the high score category for each of this index, as compared to the Control group PCPs. An average of 8 months from the time of the initial email sent on 7/21/11. No
Secondary To determine if a change in Stage of Diagnosis of Oral Cancer occurred for the particular year of Web-based Educational Intervention. Three years post-web-based education intervention data will be requested from Ohio Cancer Incidence Surveillance System (OCISS). OCISS's cleaning and processing of the data takes approximately three years. Comparison using Chi-square will be carried out pre- and post- intervention years. 3 years No
Secondary Index of knowledge of risk factors for oral cancer. The list of participants will be sent an initial email inviting them to view the module and complete a pre test (control group) or a post test (intervention group). Reminder emails will be sent every 2 months for up to 6 months following the initial email. It is expected that at least a 15% higher proportion of Intervention group PCP's will attain the high score category for this index, as compared to the Control group PCP's. An average of 8 months from the time of the initial email sent on 7/21/11. No
See also
  Status Clinical Trial Phase
Recruiting NCT06031337 - Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study
Completed NCT00158678 - IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC Phase 3
Completed NCT00933387 - A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma Phase 2
Enrolling by invitation NCT05030597 - Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma N/A
Completed NCT03682562 - Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions
Recruiting NCT03684707 - Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions Phase 4
Recruiting NCT06130332 - Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004) Phase 2
Recruiting NCT04372914 - Prevention of Oral DNA Damage by Black Raspberries N/A
Active, not recruiting NCT03529422 - Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN Phase 2
Recruiting NCT03686020 - Sensitivity and Specificity of Serum and Salivary CYFRA21-1 in the Detection of Malignant Transformation in Oral Potentially Malignant Mucosal Lesions (Diagnostic Accuracy Study)
Not yet recruiting NCT06060288 - Diagnostic Accuracy of Mobile Phone Imaging Compared to Conventional Clinical Examination for Oral Cancer Screening
Withdrawn NCT00951470 - Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema N/A
Completed NCT00964977 - Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis. Phase 3
Completed NCT01418118 - Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery Phase 4
Active, not recruiting NCT00232960 - Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC N/A
Recruiting NCT05429099 - Mandibular Reconstruction Preplanning (ViPMR) Phase 2/Phase 3
Completed NCT04614896 - Use of Ultrasound for Measuring Size of Oral Tongue Cancers N/A
Recruiting NCT03685409 - Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant Lesions Phase 3
Completed NCT00402779 - Erlotinib Prevention of Oral Cancer (EPOC) Phase 3
Recruiting NCT05153733 - Improved Implant for Reconstruction Purposes After Mandibular Resection N/A